Shared neutrophil and T cell dysfunction is accompanied by a distinct interferon signature during severe febrile illnesses in childrenNATURE COMMUNICATIONSIF15.72024-09-190OAAI
mRNA or ChAd0x1 COVID-19 Vaccination of Adolescents Induces Robust Antibody and Cellular Responses With Continued Recognition of Omicron Following mRNA-1273FRONTIERS IN IMMUNOLOGYIF5.92022-06-024OAAI
Cutaneous manifestations of paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2: a single-centre experienceBRITISH JOURNAL OF DERMATOLOGYIF9.62022-03-070PRE
Systemic Inflammation Is Associated With Neurologic Involvement in Pediatric Inflammatory Multisystem Syndrome Associated With SARS-CoV-2NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATIONIF7.52021-07-0122OAAI
Severe refractory Kawasaki disease in seven infants in the COVID-19 eraLANCET RHEUMATOLOGYIF16.42020-09-017OAAI
Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infectionNATURE MEDICINEIF502020-08-18298OAAI
Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONIF552020-07-211.4KOAAI
Presentation of life-threatening invasive nontyphoidal Salmonella disease in Malawian children: A prospective observational studyPLOS NEGLECTED TROPICAL DISEASESIF3.42017-12-0720OAAI
BREATHER (PENTA 16) short-cycle therapy (SCT) (5 days on/2 days off) in young people with chronic human immunodeficiency virus infection: an open, randomised, parallel-group Phase II/III trialHEALTH TECHNOLOGY ASSESSMENTIF42016-06-0121OA
Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trialLANCET INFECTIOUS DISEASESIF312016-02-0136OAAI
Comparison of previous and present World Health Organization clinical staging criteria in HIV-infected Malawian childrenAIDSIF3.12009-09-102OAAI
DEVELOPING THE ROLE OF THE RTT IN POSITION VERIFICATIONRADIOTHERAPY AND ONCOLOGYIF5.32009-08-011PREAI